Major depressive disorder affects millions of individuals globally, requiring long-term pharmacological intervention. While medications like amitriptyline and citalopram provide relief, they often cause significant metabolic side effects. Specifically, understanding antidepressant-induced weight gain mechanisms is crucial for improving patient adherence and long-term health outcomes. Consequently, a recent study investigated how these drugs directly influence adipose tissue function at the cellular level.

The research focused on 3T3-L1 adipocytes, which are commonly used to study fat cell development. To achieve this, investigators exposed these cells to clinically relevant concentrations of amitriptyline and citalopram. They measured changes over short-term and long-term periods. Interestingly, the results indicated that both drugs initially suppressed key adipogenic markers, including PPARα and PPARγ. Furthermore, the secretion of essential adipokines like leptin and adiponectin decreased significantly during early exposure.

Examining Antidepressant-Induced Weight Gain Mechanisms

As the exposure continued, the researchers observed distinct recovery profiles for each drug. For instance, citalopram showed a better restoration of adipogenic signaling markers compared to amitriptyline. Conversely, amitriptyline induced sustained stress signaling, marked by an increase in C/EBPβ. Moreover, amitriptyline showed stronger lipid peroxidation, indicating higher oxidative stress within the tissue.

The study also examined inflammatory markers within the adipocytes. While both drugs caused mild elevations in inflammatory cytokines, the effects were more pronounced in cells treated with amitriptyline. These findings highlight that antidepressants do not just act on the central nervous system. Instead, they exert direct, tissue-specific actions on fat cells that contribute to metabolic dysregulation.

Clinicians should consider these cellular effects when selecting therapy for patients at high metabolic risk. Citalopram may offer a lower metabolic burden for long-term use compared to tricyclic options like amitriptyline. Future studies involving human adipocytes will further clarify these pathways and help refine psychiatric treatment strategies.

Frequently Asked Questions

Why do some antidepressants cause more weight gain than others?

Different antidepressants interact with adipocytes in unique ways. Research suggests that certain drugs, like amitriptyline, cause more sustained stress signaling and oxidative stress in fat cells, whereas others like citalopram allow for better functional recovery.

Can antidepressants directly affect fat cells without systemic influence?

Yes, in vitro studies show that antidepressants like amitriptyline and citalopram can modulate adipogenic signaling and adipokine secretion directly at the cellular level, independent of appetite changes or systemic hormones.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional opinion. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Balcı Özyurt A et al. In Vitro Investigation of the Toxicity Mechanisms of Antidepressant Drugs on Adipose Tissue in 3T3-L1 Cells. J Appl Toxicol. 2026 Feb 15. doi: 10.1002/jat.70083. PMID: 41691708.

Mouawad M, et al. Impact of Antidepressants on Weight Gain: Underlying Mechanisms and Mitigation Strategies. Archives of Clinical and Biomedical Research. 2025; 9(3): 183-195.

Mathur A, et al. Efficacy and safety of citalopram versus amitriptyline in the treatment of major depression. Indian Journal of Psychiatry. 2005; 47(2): 101-105.